5.8 | | Sult2a1 | 'AZD7507; AZD5069 (at same dosage); 100 milligram per kilogram' vs 'none' | compound | RNA-seq to investigate differentially expressed genes in KPC mouse PDAC treated with CSF-1R small molecule inhibitor AZD7507 and/or the CXCR2 small molecule inhibitor AZD5069 |
5.3 | | Sult2a1 | 'transgenic hepatic growth hormone' vs 'wild type genotype' in '40 week' | age, genotype | Hepatic Deletion of Janus Kinase 2 Counteracts Inflammation, Oxidative Stress and Liver Cancer Formation in Growth Hormone Transgenic Mice |
4.7 | | Sult2a1 | 'hepatocyte-specific deletion of JAK2' vs 'wild type genotype' in '40 week' | age, genotype | Hepatic Deletion of Janus Kinase 2 Counteracts Inflammation, Oxidative Stress and Liver Cancer Formation in Growth Hormone Transgenic Mice |
3.9 | | Sult2a1 | 'Alb-Cre-ERT2 / Cnot1 flox/flox' vs 'Cnot1 flox/flox' in 'none' | compound, genotype, time | RNA-seq of livers in control and Cnot1 tamoxifen-inducible liver-specific knockout mice |
3.8 | | Sult2a1 | 'transgenic hepatic growth hormone and hepatocyte-specific deletion of JAK2' vs 'wild type genotype' in '40 week' | age, genotype | Hepatic Deletion of Janus Kinase 2 Counteracts Inflammation, Oxidative Stress and Liver Cancer Formation in Growth Hormone Transgenic Mice |
3.7 | | Sult2a1 | 'streptozotocin' vs 'mock' | treatment | Liver adapts mitochondrial function to insulin-resistant and diabetic states in mice |
3.6 | | Sult2a1 | '21 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
-3.6 | | Sult2a1 | 'Mdr2-knockout' vs 'wild type' | genotype | Gene Expression Data for female C57BL/6, Mdr2-KO and Mdr2-KO/IL6-KO at the age of 14 months |
3.3 | | Sult2a1 | '730 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
3.1 | | Sult2a1 | '30 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
3.1 | | Sult2a1 | '14 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
3 | | Sult2a1 | '365 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
3 | | Sult2a1 | 'ko cyld-/-' vs 'wild type' | genotype | Transcription profiling by array of mouse liver with Cyld inactivation |
-2.8 | | Sult2a1 | 'Mdr2-knockout/IL-6-knockout' vs 'wild type' | genotype | Gene Expression Data for female C57BL/6, Mdr2-KO and Mdr2-KO/IL6-KO at the age of 14 months |
-2.7 | | Sult2a1 | 'SARS coronavirus MA15; 2 day' vs 'mock' in 'CAST/EiJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
2.6 | | Sult2a1 | '180 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
2.6 | | Sult2a1 | 'actinomycin D; 8 hour' vs 'none' in 'Cnot1 flox/flox' | compound, genotype, time | RNA-seq of livers in control and Cnot1 tamoxifen-inducible liver-specific knockout mice |
-2.3 | | Sult2a1 | 'Influenza A virus (A/Puerto Rico/8/1934(H1N1)); 4 day' vs 'mock' in 'NOD/ShiLtJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
2.3 | | Sult2a1 | '90 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
-1.8 | | Sult2a1 | 'SARS coronavirus MA15; 2 day' vs 'mock' in 'NOD/ShiLtJ' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
1.8 | | Sult2a1 | '60 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
-1.7 | | Sult2a1 | 'liver-specific Cnot1 knockout' vs 'wild type' | phenotype | Roles of mRNA decay in liver development |
-1.6 | | Sult2a1 | 'Plasmodium chabaudi infection' vs 'no infection' in 'adjuvant only' | infect, treatment | Protective vaccination against blood-stage malaria of Plasmodium chabaudi: differential gene expression in the liver of Balb/c mice towards the end of crisis phase |
-1 | | Sult2a1 | 'actinomycin D; 8 hour' vs 'none' in 'Alb-Cre-ERT2 / Cnot1 flox/flox' | compound, genotype, time | RNA-seq of livers in control and Cnot1 tamoxifen-inducible liver-specific knockout mice |